These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 33248471)

  • 1. Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes.
    Yu B; Li C; Sun Y; Wang DW
    Cell Metab; 2021 Jan; 33(1):65-77.e2. PubMed ID: 33248471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose or Insulin, Which Is the Culprit in Patients with COVID-19 and Diabetes?
    Donath MY
    Cell Metab; 2021 Jan; 33(1):2-4. PubMed ID: 33248018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin Use, Diabetes Control, and Outcomes in Patients with COVID-19.
    Riahi S; Sombra LRS; Lo KB; Chacko SR; Neto AGM; Azmaiparashvili Z; Patarroyo-Aponte G; Rangaswami J; Anastasopoulou C
    Endocr Res; 2021; 46(2):45-50. PubMed ID: 33275067
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal function, serum magnesium levels and mortality in COVID-19 patients with type 2 diabetes.
    Pulido-Perez P; Pondigo-de Los Angeles JA; Hernandez-Hernandez ME; Torres-Rasgado E; Romero JR
    Magnes Res; 2021 Feb; 34(1):20-31. PubMed ID: 34165438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
    Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
    Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 Diabetes and COVID-19-Related Mortality in the Critical Care Setting: A National Cohort Study in England, March-July 2020.
    Dennis JM; Mateen BA; Sonabend R; Thomas NJ; Patel KA; Hattersley AT; Denaxas S; McGovern AP; Vollmer SJ
    Diabetes Care; 2021 Jan; 44(1):50-57. PubMed ID: 33097559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.
    Zhu L; She ZG; Cheng X; Qin JJ; Zhang XJ; Cai J; Lei F; Wang H; Xie J; Wang W; Li H; Zhang P; Song X; Chen X; Xiang M; Zhang C; Bai L; Xiang D; Chen MM; Liu Y; Yan Y; Liu M; Mao W; Zou J; Liu L; Chen G; Luo P; Xiao B; Zhang C; Zhang Z; Lu Z; Wang J; Lu H; Xia X; Wang D; Liao X; Peng G; Ye P; Yang J; Yuan Y; Huang X; Guo J; Zhang BH; Li H
    Cell Metab; 2020 Jun; 31(6):1068-1077.e3. PubMed ID: 32369736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes.
    Bea S; Choi A; Kim JH; Cho YM; Choi WS; Jung J; Shin JY
    Diabetes Obes Metab; 2023 Sep; 25(9):2734-2742. PubMed ID: 37312652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
    Rajpal A; Rahimi L; Ismail-Beigi F
    J Diabetes; 2020 Dec; 12(12):895-908. PubMed ID: 32671936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England.
    Khunti K; Knighton P; Zaccardi F; Bakhai C; Barron E; Holman N; Kar P; Meace C; Sattar N; Sharp S; Wareham NJ; Weaver A; Woch E; Young B; Valabhji J
    Lancet Diabetes Endocrinol; 2021 May; 9(5):293-303. PubMed ID: 33798464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients.
    Charoenngam N; Alexanian SM; Apovian CM; Holick MF
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34206813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the Clinical and Hematological Characteristics of COVID-19 Patients with and without Type 2 Diabetes.
    Sun Y; Zhao R; Hu Z; Wang W; Wang S; Gao L; Fei J; Jian X; Li Y; Zheng H; Hou X; Chen L
    J Diabetes Res; 2020; 2020():1038585. PubMed ID: 33376750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.
    Hasan SS; Kow CS; Bain A; Kavanagh S; Merchant HA; Hadi MA
    Expert Opin Pharmacother; 2021 Feb; 22(2):229-240. PubMed ID: 33054481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
    Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S
    Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching to Degludec From Other Basal Insulins Is Associated With Reduced Hypoglycemia Rates: A Prospective Study.
    Fadini GP; Feher M; Hansen TK; de Valk HW; Koefoed MM; Wolden M; Zimmermann E; Jendle J
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5977-5990. PubMed ID: 31397845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
    Zhao R; Sun Y; Zhang Y; Wang W; Wang S; Wang C; Liu J; Gao L; Hu Z; Fei J; Hou X; Zheng H; Chen L
    Mediators Inflamm; 2020; 2020():6914878. PubMed ID: 33061829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health utility of type 2 diabetes patients using basal insulin in China: results from the BEYOND II study.
    Li C; Zhou H; Wang P
    Acta Diabetol; 2021 Mar; 58(3):329-339. PubMed ID: 33067724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role of glycation and methylation for SARS-CoV-2 infection in diabetes?
    Sartore G; Ragazzi E; Faccin L; Lapolla A
    Med Hypotheses; 2020 Nov; 144():110247. PubMed ID: 33254553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea.
    You JH; Lee SA; Chun SY; Song SO; Lee BW; Kim DJ; Boyko EJ
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):901-908. PubMed ID: 33297603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.